Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

178 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Evolocumab on top of empagliflozin improves endothelial function of individuals with diabetes: randomized active-controlled trial.
Sposito AC, Breder I, Barreto J, Breder J, Bonilha I, Lima M, Oliveira A, Wolf V, Luchiari B, do Carmo HR, Munhoz D, Oliveira D, Coelho-Filho OR, Coelho OR, Matos-Souza JR, Moura FA, de Carvalho LSF, Nadruz W, Quinaglia T, Kimura-Medorima ST; EXCEED-BHS3 Group. Sposito AC, et al. Among authors: wolf v. Cardiovasc Diabetol. 2022 Aug 6;21(1):147. doi: 10.1186/s12933-022-01584-8. Cardiovasc Diabetol. 2022. PMID: 35933413 Free PMC article. Clinical Trial.
Rationale and design of the Brazilian diabetes study: a prospective cohort of type 2 diabetes.
Barreto J, Wolf V, Bonilha I, Luchiari B, Lima M, Oliveira A, Vitte S, Machado G, Cunha J, Borges C, Munhoz D, Fernandes V, Kimura-Medorima ST, Breder I, Fernandez MD, Quinaglia T, Oliveira RB, Chaves F, Arieta C, Guerra-Júnior G, Avila S, Nadruz W, Carvalho LSF, Sposito AC; Brazilian Heart Study Group. Barreto J, et al. Among authors: wolf v. Curr Med Res Opin. 2022 Apr;38(4):523-529. doi: 10.1080/03007995.2022.2043658. Epub 2022 Mar 2. Curr Med Res Opin. 2022. PMID: 35174749
Dapagliflozin increases the lean-to total mass ratio in type 2 diabetes mellitus.
Wolf VLW, Breder I, de Carvalho LSF, Soares AAS, Cintra RM, Barreto J, Munhoz DB, Kimura-Medorima ST, Nadruz W, Guerra-Júnior G, Quinaglia T, Muscelli E, Sposito AC; Addenda-BHS2 trial investigators. Wolf VLW, et al. Nutr Diabetes. 2021 Jun 12;11(1):17. doi: 10.1038/s41387-021-00160-5. Nutr Diabetes. 2021. PMID: 34120150 Free PMC article. Clinical Trial.
Dapagliflozin reduces adiposity and increases adiponectin in patients with type 2 diabetes and atherosclerotic disease at short-term: An active-controlled randomised trial.
Breder I, Wolf VLW, Soares AAS, de Carvalho LSF, Kimura-Medorima ST, Cintra RM, Barreto J, Munhoz DB, Cunha JS, Bonilha I, Coelho-Filho OR, Quinaglia T, Nadruz W, Guerra-Junior G, Muscelli E, Sposito AC; ADDENDA-BHS2 Trial Investigators. Breder I, et al. Diabetes Metab. 2022 Mar;48(2):101304. doi: 10.1016/j.diabet.2021.101304. Epub 2021 Nov 19. Diabetes Metab. 2022. PMID: 34808345 Clinical Trial. No abstract available.
Structure of the yeast ceramide synthase.
Schäfer JH, Clausmeyer L, Körner C, Esch BM, Wolf VN, Sapia J, Ahmed Y, Walter S, Vanni S, Januliene D, Moeller A, Fröhlich F. Schäfer JH, et al. Among authors: wolf vn. Nat Struct Mol Biol. 2024 Nov 11. doi: 10.1038/s41594-024-01415-2. Online ahead of print. Nat Struct Mol Biol. 2024. PMID: 39528796
Cytokine-armed vaccinia virus promotes cytotoxicity toward pancreatic carcinoma cells via activation of human intermediary CD56dimCD16dim natural killer cells.
Wang R, Hu M, Lozzi I, Jin CZJ, Ma D, Splith K, Mengwasser J, Wolf V, Feldbrügge L, Tang P, Timmermann L, Hillebrandt KH, Kirchner M, Mertins P, Hilfenhaus G, Neumann CCM, Kammertoens T, Pratschke J, Malinka T, Sauer IM, Noessner E, Guo ZS, Felsenstein M. Wang R, et al. Among authors: wolf v. Int J Cancer. 2024 Oct 14. doi: 10.1002/ijc.35209. Online ahead of print. Int J Cancer. 2024. PMID: 39400317
178 results